Pre-operative Immunotherapy Combination Strategies in Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Breast Cancer
Related studies linked through entity extraction aliases.
Pilot Study Describing the Early Evolution of the Sexual Function of Patients Receiving Adjuvant Hormone Therapy for Breast Cancer
- Status
- UNKNOWN
- Phase
- N/A
Effectiveness of Peer Support on Quality of Life in Recently Diagnosed Breast Cancer Patients
- Status
- COMPLETED
- Phase
- NA
A Trial of SHR-1210 (an Anti-PD-1 Antibody) in Combination With Apatinib in Patients With Advanced TNBC
- Status
- COMPLETED
- Phase
- PHASE2
Study of Pembrolizumab Plus Fulvestrant in Hormone Receptor Positive, HER-2 Negative Advanced/Metastatic Breast Cancer Patients
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Pharmacodynamic Biomarkers of Standard Anti-microtubule Drugs as Assessed by Early Tumor Biopsy
- Status
- TERMINATED
- Phase
- N/A
Bupivacaine Versus Liposomal Bupivacaine For Breast Pain Management After Breast Recontruction
- Status
- WITHDRAWN
- Phase
- PHASE2
Stereotactic Body Radiation Therapy for Spinal Metastases in Favorite Tumors
- Status
- RECRUITING
- Phase
- PHASE2
PBMT for the Prevention of CIPN
- Status
- COMPLETED
- Phase
- NA
Prognostic and Predictive Factors for Small Breast Tumors
- Status
- COMPLETED
- Phase
- N/A
Speeding Recovery From Pain and Opioid Use
- Status
- WITHDRAWN
- Phase
- EARLY_PHASE1
HER2 Directed Dendritic Cell Vaccine During Neoadjuvant Therapy of HER2+Breast Cancer
- Status
- COMPLETED
- Phase
- EARLY_PHASE1
AKY15-HK-301_NEPA Study
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Prospective Validation of 3D Dose Metrics as Selection Criteria for Adaptive Radiotherapy in Breast Cancer Patients
- Status
- COMPLETED
- Phase
- N/A
Targeted eHealth Intervention to Reduce Fear of Recurrence Among Breast Cancer Survivors
- Status
- COMPLETED
- Phase
- NA
The Use of 18F-ALF-NOTA-PRGD2 PET/CT Scan to Predict the Efficacy and Adverse Events of Apatinib in Malignancies.
- Status
- COMPLETED
- Phase
- PHASE4
Multi-Targeted Recombinant Ad5 (CEA/MUC1/Brachyury) Based Immunotherapy Vaccine Regimen in People With Advanced Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Study of Moderate Dose Omega 3 Fatty Acid Supplement in Premenopausal Women at High Risk for Breast Cancer
- Status
- UNKNOWN
- Phase
- NA
Effect of Radiotherapy Variables on Circulating Effectors of Immune Response and Local Microbiome
- Status
- COMPLETED
- Phase
- N/A
IMX-110 in Patients With Advanced Solid Tumors
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2